<DOC>
	<DOCNO>NCT00968851</DOCNO>
	<brief_summary>This study conduct determine safety effect cognitive function two different dos investigational medication , EVP-6124 , individual schizophrenia chronic stable atypical anti-psychotic therapy . In addition , behavioral psychotic symptom evaluate .</brief_summary>
	<brief_title>Safety Cognitive Function Study EVP-6124 Patients With Schizophrenia</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , Phase 2 safety/efficacy study two dose level EVP-6124 evaluate . Eligible enrollment patient meet clinical criterion schizophrenia take chronic atypical anti-psychotic medication stable dose . This study therefore evaluate effect EVP-6124 administer concomitantly anti-psychotic medication . Patients randomize one follow group : 0.3 mg 1.0 mg EVP-6124 , placebo . Seventy-five patient per group . Study drug supply capsule orally administer daily total 84 day .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Central Nervous System Diseases</mesh_term>
	<mesh_term>Nicotinic Agonists</mesh_term>
	<criteria>Subjects meet clinical criterion schizophrenia schizoaffective disorder utilizing structure clinical interview ( SCI ) Must treat second generation antipsychotic drug clozapine stable dose least 4 week must drug clinically stable least 8 week Must `` moderate '' severity rating negative symptom : BPRS item ≤4 A minimal level extrapyramidal symptom ( EPS ) ; SimpsonAngus Scale total score ≤6 A minimal level depression ; Calgary Depression Scale total score ≤10 Must general health status acceptable participation 12week clinical trial Fluency ( oral write ) language standardized test administer If smoker , ability refrain smoke least 30 minute prior cognitive test General Insufficiently control diabetes mellitus judgment investigator Malignant tumor within last 5 year exception squamous basal cell carcinoma cervical carcinoma situ Pregnancy , nursing , ( fertile female ) willing utilize birth control measure study Unstable medical condition clinically significant judgment investigator : major organ system dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Central nervous System Diseases</keyword>
	<keyword>Cognition</keyword>
</DOC>